Concepedia

Publication | Closed Access

Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction

DOI

47

Citations

27

References

2016

Year

Martin Reindl, Sebastian J. Reinstadler, Hans‐Josef Feistritzer, Lukas A. Mueller, Constantin Koch, Agnes Mayr, Markus Theurl, Rudolf Kirchmair, Gert Klug, Bernhard Metzler
Heart

Abstract

Circulating FGF-23 is independently associated with LV remodelling after reperfused STEMI. A comprehensive multimarker strategy that includes FGF-23 provides incremental prognostic value for prediction of LV remodelling.

References

YearCitations

Page 1